GemPharmatech's ambitious Knockout All Project (KOAP) aims to create knockout (KO) and conditional knockout (cKO) mouse strains for all ~23,000 protein coding genes in the mouse genome. Our specialized gene editing platform enables the production of over 6,000 new mutant strains annually, generating KO and cKO mice quickly and efficiently. To date, we have successfully targeted more than 11,500 genes, providing researchers with knockout mouse models and conditional knockout mouse models for a wide range of research fields, including oncology, autoimmunity, metabolism, and neurodegeneration. Our ultimate goal at GemPharmatech is to provide our customers with the best mouse tools to accelerate their biomedical discovery and drug development.
